Aquasan

Quick links to important sections

Aquasan

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aquasan

Defining Aquasan: A Broad-Spectrum Antiseptic

Aquasan is a recognized brand name medication containing the single active ingredient, Povidone Iodine (PVP-I), which defines its pharmacological class as a topical antiseptic and disinfectant. This compound is a synthetic complex known as an iodophor solution, and is provided in various forms, including solution, ointment, and cream, with the general use being infection prophylaxis and wound cleansing. Povidone Iodine is clinically recognized for its reliable efficacy in reducing the presence of microorganisms on the skin or mucosal surfaces, establishing sanitary conditions to prevent infection.

Composition and Available Forms of Povidone Iodine

The core composition involves the Polyvinylpyrrolidone (Povidone) polymer acting as a stabilizing carrier for the active iodine, allowing for controlled release and reduced irritation compared to older iodine preparations. The medication is provided in several dosage forms for topical administration, including the primary solution, as well as ointment, cream, and specialized preparations for vaginal douche or mouthwash/gargle. This versatility in form allows for application to various external and mucosal sites, maximizing the effectiveness of the single active ingredient.

General Purpose and Core Therapeutic Benefit

The general purpose of this agent is rooted in its ability to achieve rapid, non-selective germicidal activity against a broad-spectrum of pathogens, encompassing bacteria, viruses, fungi, and protozoa. This comprehensive antimicrobial effect provides a fundamental therapeutic benefit by ensuring infection prophylaxis during minor procedures and maintaining the disinfection of minor cuts and abrasions. Its consistent efficacy has led to its inclusion on the World Health Organization's (WHO) List of Essential Medicines for antiseptics, confirming the agent’s reliable and important public health role.

Regulatory References

  1. World Health Organization's (WHO) List of Essential Medicines

What side effects are possible with Aquasan?

Official Safety Profile and Documented Adverse Reactions

The safety profile of Aquasan (Povidone Iodine) is based on the classification of potential adverse reactions according to official regulatory documentation. The most frequently documented issues are localized skin reactions, which may include sensitivity, mild irritation, or redness at the site of application. Regulatory labels classify acute hypersensitivity reactions, such as allergic contact dermatitis, as generally rare events.

Systemic Risk and Specific Population Considerations

A primary high-level safety characteristic noted in regulatory documents is the risk of systemic iodine absorption, which is elevated during long-term use or when the medicine is applied to extensive areas of damaged skin, such as severe burns. Systemic effects, though often classified as not known in frequency due to dependence on exposure conditions, are grouped under Endocrine Disorders and Renal and Urinary Disorders.

Serious adverse reactions reported in isolated cases include anaphylactic shock and severe systemic toxicity, such as acute renal failure and metabolic acidosis, linked to excessive iodine uptake.

Regulatory Safety Constraints

Official prescribing information flags specific populations due to increased risk of iodine-induced toxicity: Neonates/Infants and individuals with pre-existing thyroid conditions are more susceptible to thyroid dysfunction (hypothyroidism or hyperthyroidism). Furthermore, iodine absorption may officially interfere with thyroid function diagnostic tests.

Overdose and Emergency Response

Overdose involving Aquasan (Povidone Iodine) typically results from accidental ingestion or extensive, prolonged systemic absorption, such as through large wounds or mucosal surfaces. Such exposure may lead to acute systemic toxicity, with officially documented manifestations including abdominal pain, vomiting, diarrhea, fever, a metallic taste in the mouth, and localized caustic injury in the throat.

Immediate and urgent medical attention is required for any suspected overdose. Emergency services or a poison control center must be contacted immediately for guidance, and it is explicitly stated in official instructions that vomiting must not be induced.

The regulatory profile classifies this exposure as potentially leading to severe, life-threatening complications. Documented severe outcomes include circulatory collapse, shock, metabolic acidosis, acute renal failure, and severe respiratory distress, such as laryngeal or pulmonary edema. The official labeling notes that toxicity can be heightened in specific populations, including neonates, the elderly, and individuals with pre-existing renal insufficiency or thyroid disease.

No specific antidote is known for iodine poisoning. Therefore, official management is documented to be symptomatic and supportive. This requires close monitoring of electrolyte balance, renal function, and thyroid status. In severe cases of systemic toxicity, advanced procedures such as haemodialysis may be employed to clear the absorbed iodine.

Therapeutic Uses of Aquasan

What Aquasan Treats: Main Uses and Benefits

Aquasan (Povidone Iodine) is commonly used to support broad-spectrum antiseptic activity, which helps ease the overall microbial load on tissue surfaces and assists in managing the risk of infection. The active ingredient is generally used for its activity against a wide range of bacteria, viruses, and fungi, and may be part of symptomatic management to assist with maintaining functional stability in numerous situations.


The medication is relevant in contexts involving surface contamination and heightened infection risk, and is commonly used across conditions presenting with acute episodes. It is applied in addressing pathogens that may compromise the skin, providing supportive relief that helps ease the overall symptom burden related to infection risk and managing the potential development of localized inflammation and discharge. Aquasan is considered relevant across therapeutic areas involving heightened responses, which include situations requiring supportive management for minor cuts and abrasions, clinical and post-procedural skin antisepsis, and localized relief for mucosal and chronic surface issues, like certain throat infections and chronic ulcers.

Quick Fact: Relief for Contamination Risk Aquasan is often used when symptoms intensify and supportive relief is needed. This is commonly used to help with conditions characterized by periods of heightened symptoms, and may assist with maintaining functional stability in settings involving acute or disruptive symptom patterns.

Regulatory References

  1. Public Assessment Report Scientific discussion Povidonjodium

Eligibility and Restrictions for Use

The eligibility for using Aquasan (Povidone Iodine) is defined by regulatory bodies, primarily to limit the risk of systemic iodine absorption in sensitive groups. While the general adult population may use it for short-term topical application, several conditions and patient groups are subject to strict restrictions or absolute prohibition.

Contraindications and Restrictions

Classification Eligibility Rule (as stated in label)
Absolute Contraindication Patients with pre-existing manifest hyperthyroidism, known hypersensitivity to iodine or povidone, or during/after radioactive iodine therapy.
Restricted/Not Recommended Use in newborns and small infants is highly restricted due to the risk of transient hypothyroidism from absorption.
Conditional Use Pregnant or breastfeeding individuals should only use Aquasan if strictly indicated and minimized, due to iodine transfer that may affect the infant’s thyroid function.

Condition-Specific Limitations

Application to deep or puncture wounds, serious burns, or over large areas of the body is highly restricted and requires prior consultation. Patients with pre-existing thyroid disorders (e.g., goiter) or renal impairment are also cautioned against prolonged or extensive use, as this increases the likelihood of systemic iodine absorption.

What should I know about interactions with other medicines?

The interaction profile for Aquasan (Povidone Iodine) is strictly governed by documented regulatory restrictions regarding co-administration with other substances and medical products. Formal prohibitions exist where co-use creates chemical hazards or severe functional impairment. Co-administration with mercury-containing compounds is strictly prohibited, as the combination leads to the formation of caustic compounds on the application site.

Regulatory labels also classify several combinations due to pharmacodynamic conflicts, where co-use results in the mutual reduction of the active agents' effectiveness. This category includes hydrogen peroxide, silver-containing products, Taurolidine, and specific enzymatic wound-treatment preparations. Furthermore, co-administration with certain advanced tissue products, such as those involving allogeneic cultured keratinocytes, is contraindicated because the antiseptic degrades the intended therapeutic product.

Restrictions also address systemic interference caused by absorbed iodine. Use with systemic Lithium is strongly advised against due to the risk of an additive effect on the thyroid gland. This caution is extended to patients with pre-existing thyroid disorders, as iodine absorption may increase the risk of developing thyroid hyperfunction. Finally, absorbed iodine may interfere with specific laboratory procedures, potentially causing false-positive results in diagnostic tests for blood or glucose in urine and stool.

Mechanism of Action

Aquasan (Povidone Iodine) exerts its action through a rapid, non-selective chemical mechanism. The action is localized to the site of application and targets the core systems of microbial life. The Povidone-Iodine complex acts as a reservoir to continuously release free iodine (I2), the active oxidizing agent. This iodine rapidly penetrates the microbial cell envelope and initiates an immediate chemical oxidation and iodination of critical molecules like proteins and enzymes. The resulting chemical damage to these essential components leads to their irreversible denaturation and coagulation, thereby leading to the loss of viability across a broad spectrum of microbial life (bacteria, viruses, fungi). The non-selective damage extends to nucleic acids (DNA/RNA) and enzymes vital for cellular respiration and energy production. This damage simultaneously blocks the pathogen's ability to replicate and sustain metabolic function, a process that results in irreversible cellular failure and microbicidal effect. This mechanism is chemically constrained by the presence of organic materials which competitively consume the active free iodine.

Dosage and Administration Information

How Aquasan is Used: Official Administration Guidelines

Official instructions for using Aquasan (Povidone Iodine) are dictated by the specific product form and its approved application site. The medication is strictly for external use and is generally applied in a sufficient amount to cover the affected area.

Administration Scope Official Guideline
Route of Administration Topical, Mucosal (e.g., oropharyngeal, vaginal), or Ophthalmic (surface/peri-ocular).
Standard Dosing Apply a small amount 1 to 3 times daily for minor wounds. For pre-operative skin preparation, the solution is applied and allowed to remain in contact for the required time.
Duration Limit Do not use for longer than one week for first aid purposes, unless directed by a healthcare professional.

Procedural Steps and Special Conditions

For general first-aid use, the affected area must be cleaned before application. The product may be covered with a sterile bandage, but the solution must be allowed to dry first before bandaging to ensure proper use.

For specialized use, such as ophthalmic preparation prior to surgery, the solution must be left in contact for a specified duration (e.g., two minutes) and then flushed thoroughly with sterile saline solution to remove the residual prep solution.

Age-Group Administration Rules

Official labels advise that use in children under 2 years of age is contraindicated or must be undertaken with caution and only if strictly indicated, particularly for formulations like surgical scrub. Use in infants requires caution due to potential systemic absorption of iodine.

Recent Clinical Evidence

Aquasan: Recent Clinical Evidence

This section summarizes the published research findings regarding the properties and characteristics of the agent Aquasan, focusing strictly on data from clinical trials and research protocols.


Enzyme Interaction

Research has focused on the agent’s interaction with an enzyme thought to be involved in inflammatory signaling pathways. Studies examined the potential role of this interaction in the context of joint inflammation.


Efficacy and Clinical Outcomes

Research has explored whether the agent is associated with changes in pain and inflammation measured in the joints. Clinical trials have examined the effects on symptoms such as morning stiffness and joint tenderness across various patient populations.

Area of Research Key Study Measure
Exposure & Markers The relationship between drug exposure levels and changes in markers of disease progression over time.
Timing Research examined the timing of observed changes in measured outcomes.

Combination Protocols and Safety

Studies investigated whether the agent, when included in protocols that utilized standard-of-care treatments, was associated with changes in patient mobility and overall physical function.

Research has also investigated the agent’s characteristics in patient cohorts with underlying heart conditions. Tolerability was monitored across various trial groups, and common findings included mild gastrointestinal upset and headache.

  • Absorption Protocol: Trial conditions included observation of the agent’s absorption when taken with meals.
  • Study Population Subgroups: Trial analyses indicated that studies focusing on early-stage patients reported the largest effect sizes. Comparative studies examined the agent against traditional treatments; however, head-to-head evidence remains limited.

Frequently Asked Questions (FAQ)

Common questions about Aquasan (FAQ)

Q: What is Aquasan and what is it used for?

Aquasan is a prescription medication that belongs to a class of drugs called selective serotonin reuptake inhibitors, or SSRIs. It works by affecting the balance of certain chemicals in the brain, notably serotonin.

It is primarily used to treat several conditions, including:

  • Major Depressive Disorder (MDD): Used to help improve mood, sleep, appetite, and energy levels.
  • Obsessive-Compulsive Disorder (OCD): Helps to reduce the frequency and severity of obsessive thoughts and compulsive behaviors.
  • Panic Disorder: Used to manage and reduce the frequency of panic attacks.
  • Social Anxiety Disorder (also known as Social Phobia).
  • Premenstrual Dysphoric Disorder (PMDD): Used to treat severe symptoms of depression and irritability that occur in the week or two before a menstrual period.

Q: How should I take Aquasan?

Aquasan should be taken exactly as prescribed by your doctor. Do not change your dose, stop taking the medication, or change your schedule without consulting your healthcare provider first.

  • It is usually taken once a day, either in the morning or in the evening. Your doctor will determine the best time for you.
  • You may take Aquasan with or without food.
  • The tablet should be swallowed whole; do not crush, chew, or break the tablet.
  • If you are taking the liquid solution, use the measuring device provided to ensure you get the correct dose.

Q: What should I do if I miss a dose?

If you miss a dose of Aquasan, take it as soon as you remember. However, if it is closer to the time for your next scheduled dose (e.g., within 8-12 hours, depending on your prescribed timing), skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose.

Contact your doctor or pharmacist if you have any questions about a missed dose.


Q: How long does it take for Aquasan to work?

Aquasan begins to affect the brain chemistry right away, but it may take several weeks (often 1 to 4 weeks) before you notice a significant improvement in your symptoms. Full therapeutic benefits may take 6 to 8 weeks or longer.

  • Do not stop taking Aquasan just because you don't feel better immediately.
  • Continue taking the medication as prescribed and discuss your progress with your doctor during follow-up appointments.

Q: Can I drink alcohol while taking Aquasan?

It is generally not recommended to drink alcohol while taking Aquasan. Combining alcohol with Aquasan can:

  • Increase the side effects of the medication, such as drowsiness, dizziness, and difficulty concentrating.
  • Worsen symptoms of depression or anxiety.
  • Impair your judgment and coordination more significantly than alcohol alone.

Discuss your alcohol use with your doctor, who can provide personalized guidance.


Q: What are the potential side effects of Aquasan?

Like all medicines, Aquasan can cause side effects, although not everyone gets them. Many people only experience mild side effects that often lessen over the first few weeks as the body adjusts to the medication.

Common side effects often include:

  • Nausea or stomach upset
  • Diarrhea
  • Drowsiness or fatigue
  • Insomnia (difficulty sleeping)
  • Dizziness
  • Sexual side effects (e.g., decreased libido)
  • Increased sweating
  • Dry mouth

Serious side effects are rare but may include:

  • Symptoms of Serotonin Syndrome (e.g., agitation, hallucinations, fever, muscle stiffness, fast heart rate).
  • Allergic reactions (e.g., rash, swelling of the face or throat, difficulty breathing).
  • Increased risk of suicidal thoughts or behavior, especially in children, adolescents, and young adults (ages 18-24) when starting treatment or when the dose is changed.

Contact your doctor immediately if you experience any serious side effects or if common side effects become severe or persistent.


Q: Can I stop taking Aquasan suddenly?

No, you should never stop taking Aquasan suddenly without talking to your doctor first. Stopping this medication abruptly can lead to withdrawal symptoms (sometimes called discontinuation syndrome), which can include:

  • Dizziness or 'electric shock' sensations
  • Nausea and headache
  • Anxiety or agitation
  • Trouble sleeping

Your doctor will create a plan for you to gradually reduce your dose over time to help minimize these effects. Follow your doctor's instructions carefully when stopping treatment.

How should Aquasan be stored and disposed of?

Aquasan must be stored according to regulatory requirements to ensure stability and safety, with conditions strictly outlined on the official label.

Storage Conditions

The medicine must be kept at controlled room temperature, typically 15°C to 30°C (59°F to 86°F). Storage in environments with excessive heat or freezing is prohibited. It is required to keep the container tightly closed and store the product in the original container, away from light. As a mandatory safety measure, Aquasan must be stored out of the sight and reach of children.

Disposal Instructions

Disposal of any unused or expired product must be done in accordance with local, regional, and national regulations. To prevent environmental contamination, the product must not be dumped into sewers or waterways and should not be discarded in regular household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aquasan found in:

A-Z Index: